Balaglitazone, a new thiazotidinedionc, improves glucose and lipid control in patients with type 2 diabetes

被引：0
|
作者：
Koev, D
Ionescu-Trgoviste, C
Rosenthal, A
Palacios, RTY
Söder-Ström, J
Zdravkovic, M
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A124 / A124
页数：1
相关论文
共 50 条
  • [1] Tesaglitazar improves glucose and lipid abnormalities in patients with type 2 diabetes
    Goldstein, BJ
    Rosenstock, J
    Anzalone, D
    Tou, C
    Öhman, P
    DIABETES, 2005, 54 : A21 - A21
  • [2] Repaglinide improves blood glucose control in patients with type 2 diabetes
    不详
    FORMULARY, 2004, 39 (11) : 528 - 528
  • [3] Effect of glucose control on lipid levels in patients with type 2 diabetes
    Parhofer, KG
    Laubach, E
    Geiss, HC
    Otto, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (18) : 958 - 962
  • [4] Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
    Perkovic, Vlado
    Heerspink, Hiddo Lambers
    Chalmers, John
    Woodward, Mark
    Jun, Min
    Li, Qiang
    MacMahon, Stephen
    Cooper, Mark E.
    Hamet, Pavel
    Marre, Michel
    Mogensen, Carl Erik
    Poulter, Neil
    Mancia, Giuseppe
    Cass, Alan
    Patel, Anushka
    Zoungas, Sophia
    KIDNEY INTERNATIONAL, 2013, 83 (03) : 517 - 523
  • [5] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
    Axelsson, Annika S.
    Tubbs, Emily
    Mecham, Brig
    Chacko, Shaji
    Nenonen, Hannah A.
    Tang, Yunzhao
    Fahey, Jed W.
    Derry, Jonathan M. J.
    Wollheim, Claes B.
    Wierup, Nils
    Haymond, Morey W.
    Friend, Stephen H.
    Mulder, Hindrik
    Rosengren, Anders H.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (394)
  • [6] The effect of pioglitazone on glucose control and lipid profile in patients with type 2 diabetes
    Egan, JW
    Mathisen, AL
    DIABETES, 2000, 49 : A105 - A105
  • [7] Leucine improves brain glucose and lipid metabolism in type 2 diabetes
    Erukainure, O. L.
    Olofinsan, K.
    Salau, V.
    Islam, M. S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [8] Tesaglitazar improves glucose and lipid responder rates and goal attainment in patients with type 2 diabetes
    Goldstein, B.
    Rosenstock, J.
    Anzalone, D.
    Tou, C.
    Ohman, P.
    DIABETOLOGIA, 2006, 49 : 485 - 485
  • [9] Professional Continuous Glucose Monitoring Improves Glucose Control in Type 2 Diabetes
    Leibowitz, Jonas
    Wisotsky, Daniel J.
    DIABETES, 2019, 68
  • [10] The effect of pioglitazone on glucose control and lipid profile in patients with type 2 diabetes.
    Mathisen, AL
    Schneider, R
    Rubin, C
    Houser, V
    DIABETOLOGIA, 1999, 42 : A227 - A227
12345